A Novel Methodology for Applying Multivoxel MR Spectroscopy to Evaluate Convection-Enhanced Drug Delivery in Diffuse Intrinsic Pontine Gliomas.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 26939629)

Published in AJNR Am J Neuroradiol on March 03, 2016

Authors

D I Guisado1, R Singh1, S Minkowitz2, Z Zhou3, S Haque4, K K Peck5, R J Young6, A J Tsiouris2, M M Souweidane7, S B Thakur8

Author Affiliations

1: From the Weill Medical College of Cornell University (D.I.G., R.S.), New York, NY.
2: Departments of Radiology (S.M., A.J.T.).
3: Neurological Surgery (Z.Z., M.M.S.), Weill Medical College of Cornell University, New York, New York.
4: Departments of Radiology (S.H., K.K.P., R.J.Y., S.B.T.).
5: From the Departments of Radiology (M.J., K.K.P., R.J.Y., N.B., A.I.H.) Medical Physics (K.K.P.).
6: From the Departments of Radiology (M.J., K.K.P., R.J.Y., N.B., A.I.H.) Brain Tumor Center (R.J.Y., A.I.H.), Memorial Sloan-Kettering Cancer Center, New York, New York Department of Radiology (R.J.Y., A.I.H.), Weill Medical College of Cornell University, New York, New York.
7: Neurological Surgery (Z.Z., M.M.S.), Weill Medical College of Cornell University, New York, New York Neurosurgery (M.M.S.).
8: Departments of Radiology (S.H., K.K.P., R.J.Y., S.B.T.) Medical Physics (K.K.P., S.B.T.), Memorial Sloan Kettering Cancer Center, New York, New York. thakurs@mskcc.org.

Associated clinical trials:

Convection-Enhanced Delivery of 124I-8H9 for Patients With Non-Progressive Diffuse Pontine Gliomas Previously Treated With External Beam Radiation Therapy | NCT01502917

Articles cited by this

Convection-enhanced delivery of macromolecules in the brain. Proc Natl Acad Sci U S A (1994) 6.61

Magnetic resonance spectroscopy of the brain: review of metabolites and clinical applications. Clin Radiol (2008) 2.74

The next frontier of molecular medicine: delivery of therapeutics. Nat Med (1998) 2.59

Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy. Magn Reson Med (2003) 2.44

Neoadjuvant chemotherapy of locally advanced breast cancer: predicting response with in vivo (1)H MR spectroscopy--a pilot study at 4 T. Radiology (2004) 1.95

Diffuse intrinsic pontine gliomas: a systematic update on clinical trials and biology. Cancer Treat Rev (2011) 1.48

Magnetic resonance spectroscopy. J Neuroophthalmol (2005) 1.47

Diffuse intrinsic pontine glioma: poised for progress. Front Oncol (2012) 1.41

Conventional MRI cannot predict survival in childhood diffuse intrinsic pontine glioma. J Neurooncol (2007) 1.38

Metabolic tumor imaging using magnetic resonance spectroscopy. Semin Oncol (2011) 1.22

Absolute concentrations of metabolites in human brain tumors using in vitro proton magnetic resonance spectroscopy. NMR Biomed (1997) 1.20

Apparent diffusion and fractional anisotropy of diffuse intrinsic brain stem gliomas. AJNR Am J Neuroradiol (2010) 1.14

Diffusion tensor imaging of tract involvement in children with pontine tumors. AJNR Am J Neuroradiol (2006) 1.12

Distinguishing glioma recurrence from treatment effect after radiochemotherapy and immunotherapy. Neurosurg Clin N Am (2010) 1.04

Longitudinal multivoxel MR spectroscopy study of pediatric diffuse brainstem gliomas treated with radiotherapy. Int J Radiat Oncol Biol Phys (2005) 1.03

Convection-enhanced delivery into the rat brainstem. J Neurosurg (2002) 1.03

Predicting outcome of children with diffuse intrinsic pontine gliomas using multiparametric imaging. Neuro Oncol (2011) 1.02

Proton magnetic resonance spectroscopic imaging in newly diagnosed glioblastoma: predictive value for the site of postradiotherapy relapse in a prospective longitudinal study. Int J Radiat Oncol Biol Phys (2008) 1.02

Convection-enhanced delivery for the treatment of pediatric neurologic disorders. J Child Neurol (2008) 0.98

Spectroscopic and perfusion magnetic resonance imaging predictors of progression in pediatric brain tumors. Cancer (2004) 0.94

Single- and multivoxel proton spectroscopy in pediatric patients with diffuse intrinsic pontine glioma. Int J Radiat Oncol Biol Phys (2012) 0.83

Articles by these authors

T1-Weighted Dynamic Contrast-Enhanced MRI as a Noninvasive Biomarker of Epidermal Growth Factor Receptor vIII Status. AJNR Am J Neuroradiol (2015) 1.44

Diagnostic Accuracy of T1-Weighted Dynamic Contrast-Enhanced-MRI and DWI-ADC for Differentiation of Glioblastoma and Primary CNS Lymphoma. AJNR Am J Neuroradiol (2016) 0.75

Dynamic Susceptibility Contrast-Enhanced MR Perfusion Imaging in Assessing Recurrent Glioblastoma Response to Superselective Intra-Arterial Bevacizumab Therapy. AJNR Am J Neuroradiol (2016) 0.75

Identification of the Corticobulbar Tracts of the Tongue and Face Using Deterministic and Probabilistic DTI Fiber Tracking in Patients with Brain Tumor. AJNR Am J Neuroradiol (2015) 0.75

T1-Weighted Dynamic Contrast-Enhanced MR Perfusion Imaging Characterizes Tumor Response to Radiation Therapy in Chordoma. AJNR Am J Neuroradiol (2017) 0.75

Synthetic MRI for Clinical Neuroimaging: Results of the Magnetic Resonance Image Compilation (MAGiC) Prospective, Multicenter, Multireader Trial. AJNR Am J Neuroradiol (2017) 0.75

Comparison of Gadoterate Meglumine and Gadobutrol in the MRI Diagnosis of Primary Brain Tumors: A Double-Blind Randomized Controlled Intraindividual Crossover Study (the REMIND Study). AJNR Am J Neuroradiol (2017) 0.75

Apparent diffusion coefficient in estrogen receptor-positive and lymph node-negative invasive breast cancers at 3.0T DW-MRI: A potential predictor for an oncotype Dx test recurrence score. J Magn Reson Imaging (2017) 0.75

Glioblastoma spheroids produce infiltrative gliomas in the rat brainstem. Childs Nerv Syst (2017) 0.75

Regarding "Computer-Extracted Texture Features to Distinguish Cerebral Radionecrosis from Recurrent Brain Tumors on Multiparametric MRI: A Feasibility Study". AJNR Am J Neuroradiol (2016) 0.75